Edaravone: a new treatment for ALS on the horizon?

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2 Citations (Scopus)

Access to Document

@article{36fb4e2304304b59be66e01cdf32a895,

title = "Edaravone: a new treatment for ALS on the horizon?",

author = "Orla Hardiman and {van den Berg}, {Leonard H.}",

year = "2017",

month = jul,

day = "1",

doi = "10.1016/S1474-4422(17)30163-1",

language = "English",

volume = "16",

pages = "490--491",

journal = "Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Limited",

number = "7",

}

TY - JOUR

T1 - Edaravone

T2 - a new treatment for ALS on the horizon?

AU - Hardiman, Orla

AU - van den Berg, Leonard H.

PY - 2017/7/1

Y1 - 2017/7/1

UR - http://www.scopus.com/inward/record.url?scp=85019590549&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(17)30163-1

DO - 10.1016/S1474-4422(17)30163-1

M3 - Comment/Letter to the editor

C2 - 28522180

SN - 1474-4422

VL - 16

SP - 490

EP - 491

JO - Lancet Neurology

JF - Lancet Neurology

IS - 7

ER -